Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 06; 10(11):3565-3574.

View in: PubMed

subject areas

Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Antineoplastic Combined Chemotherapy Protocols
Cardiotoxicity
Cardiovascular Diseases
Child
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Dacarbazine
Doxorubicin
Female
Heart
Humans
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Ovarian Neoplasms
Polyethylene Glycols
Product Surveillance, Postmarketing
Retrospective Studies
Sarcoma
Soft Tissue Neoplasms
Stroke Volume
Ventricular Function, Left
Young Adult

authors with profiles

Robin Jones